JP2002514578A5 - - Google Patents

Download PDF

Info

Publication number
JP2002514578A5
JP2002514578A5 JP2000547948A JP2000547948A JP2002514578A5 JP 2002514578 A5 JP2002514578 A5 JP 2002514578A5 JP 2000547948 A JP2000547948 A JP 2000547948A JP 2000547948 A JP2000547948 A JP 2000547948A JP 2002514578 A5 JP2002514578 A5 JP 2002514578A5
Authority
JP
Japan
Prior art keywords
methyl
acid
phthalimidinoglutaric
pharmaceutical composition
phthalimidinoglutaric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000547948A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002514578A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/010287 external-priority patent/WO1999058096A2/en
Publication of JP2002514578A publication Critical patent/JP2002514578A/ja
Publication of JP2002514578A5 publication Critical patent/JP2002514578A5/ja
Pending legal-status Critical Current

Links

Images

JP2000547948A 1998-05-11 1999-05-11 ２−フタルイミジノグルタル酸の類似体および血管新生の阻害剤としてのそれらの使用 Pending JP2002514578A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US8503798P 1998-05-11 1998-05-11
US9738498P 1998-08-21 1998-08-21
US10803798P 1998-11-12 1998-11-12
US60/085,037 1998-11-12
US60/097,384 1998-11-12
US60/108,037 1998-11-12
PCT/US1999/010287 WO1999058096A2 (en) 1998-05-11 1999-05-11 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis

Publications (2)

Publication Number Publication Date
JP2002514578A JP2002514578A (ja) 2002-05-21
JP2002514578A5 true JP2002514578A5 (https=) 2006-05-18

Family

ID=27374997

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000547948A Pending JP2002514578A (ja) 1998-05-11 1999-05-11 ２−フタルイミジノグルタル酸の類似体および血管新生の阻害剤としてのそれらの使用

Country Status (6)

Country Link
EP (1) EP1091726A2 (https=)
JP (1) JP2002514578A (https=)
KR (1) KR100699968B1 (https=)
AU (1) AU749356B2 (https=)
CA (1) CA2331461C (https=)
WO (1) WO1999058096A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7182953B2 (en) * 1999-12-15 2007-02-27 Celgene Corporation Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders
AU2002306596B2 (en) 2001-02-27 2008-01-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Analogs of thalidomide as potential angiogenesis inhibitors
CN1731997A (zh) * 2002-10-31 2006-02-08 细胞基因公司 使用包含选择性细胞因子抑制药物的组合物治疗和控制黄斑变性的方法
US7776907B2 (en) 2002-10-31 2010-08-17 Celgene Corporation Methods for the treatment and management of macular degeneration using cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
CN1867331B (zh) 2003-09-17 2010-05-26 美国政府健康及人类服务部 作为TNF-α调节剂的沙利度胺类似物
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
CN102603610B (zh) * 2012-02-21 2014-07-09 四川大学 1,3-二氢-1-氧-2h-异吲哚类化合物、其制备方法和用途
CN104045594B (zh) * 2012-02-21 2016-08-17 四川大学 一类1,3-二氢-1-氧-2h-异吲哚类化合物及其用途
US9617212B2 (en) 2013-12-17 2017-04-11 Controlled Chemicals, Inc. Isoindolin-1-ones as macrophage migration inhibitory factor (MIF) inhibitors
CN109467550B (zh) * 2017-12-31 2022-02-18 苏州亚科科技股份有限公司 一种邻苯二甲酰胺基-l-谷氨酸酐的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
DE4422237A1 (de) * 1994-06-24 1996-01-04 Gruenenthal Gmbh Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe

Similar Documents

Publication Publication Date Title
US6673828B1 (en) Analogs of 2-Phthalimidinoglutaric acid
CA2430669A1 (en) Synthesis of 3-amino-thalidomide and its enantiomers
JP2002514578A5 (https=)
JP2010529193A5 (https=)
JP2001509132A (ja) Ｉｍｐｄｈ酵素のインヒビターとしての尿素誘導体
JP2003509349A5 (https=)
CA2361364A1 (en) Dalda analogs and their use
JP2007529426A5 (https=)
JP3476193B2 (ja) 置換ヘキサヒドロベンゾ〔α〕フェナンスリジン類
AU749356B2 (en) Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
EP1389103A2 (en) Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
CZ100094A3 (en) 2-amino-4-quinolyl dihydropyridines, process of their preparation, medicaments in which they are comprised, process of their preparation and the use of said compounds
JPH06321939A (ja) 縮合キノリル−ジヒドロピリジン、その製造法及び薬剤におけるその利用
US4806567A (en) Method for the treatment of ischemia and reperfusion syndromes
CN1064681C (zh) 杂环化合物
JPH05213755A (ja) 肝臓障害治療薬
JP2000511909A (ja) 修飾された形態を有するｒ（―）―ｎ―（４，４―ジ（３―メチルチエン―２―イル）ブタ―３―エニル）―ニペコチン酸・塩酸塩
KR920001778B1 (ko) 신규의 (-)-2-피라졸린 화합물 및 이것의 광학분할방법
US11845809B2 (en) Maleate of SCY-635 and uses thereof in medicine
JP3345814B2 (ja) ２６―（ジアルキルアミノアルキルスルホニル）プリスチナマイシンｉｉｂから誘導される新規な塩類
WO2020118715A1 (en) Salts of scy-635 and uses thereof in medicine
JP2579116B2 (ja) 新規な４−メチル−１，３−オキサゾール化合物、それらの調製法およびそれらを含む医薬組成物
JPH03218361A (ja) ９―アシルアミノテトラヒドロアクリジン誘導体
SK48194A3 (en) 2,6-disubstituted 4-chinolyl-dihydropyridines, method of their production, treatments containing these matters, method of their production, and using of these compounds
JPH10500987A (ja) 療用複素環化合物